ECOR - electroCore, Inc.

6.175
-0.005   -0.081%

Share volume: 19,966
Last Updated: 04-24-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$6.18
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 8%
Dept financing 12%
Liquidity 51%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.90%
1 Month
5.38%
3 Months
-21.64%
6 Months
26.02%
1 Year
-16.33%
2 Year
8.33%
Key data
Stock price
$6.18
P/E Ratio 
N/A
DAY RANGE
$6.02 - $6.25
EPS 
-$1.65
52 WEEK RANGE
$4.16 - $8.64
52 WEEK CHANGE
-$16.33
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
8.084 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.79
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$32,000
AVERAGE 30 VOLUME 
$65,382
Company detail
CEO: Daniel S. Goldberger
Region: US
Website: electrocore.com
Employees: 50
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

electroCore is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Recent news